Background: Low-intensity transcranial focused ultrasound stimulation (TFUS) holds great promise as a highly focal technique for transcranial stimulation even for deep brain areas. Yet, knowledge about the safety of this novel technique is still limited. Objective: To systematically review safety related aspects of TFUS. The review covers the mechanisms-ofaction by which TFUS may cause adverse effects and the available data on the possible occurrence of such effects in animal and human studies. Methods: Initial screening used key term searches in PubMed and bioRxiv, and a review of the literature lists of relevant papers. We included only studies where safety assessment was performed, and this results in 33 studies, both in humans and animals. Results: Adverse effects of TFUS were very rare. At high stimulation intensity and/or rate, TFUS may cause haemorrhage, cell death or damage, and unintentional blood-brain barrier (BBB) opening. TFUS may also unintentionally affect long-term neural activity and behaviour. A variety of methods was used mainly in rodents to evaluate these adverse effects, including tissue staining, magnetic resonance imaging, temperature measurements and monitoring of neural activity and behaviour. In 30 studies, adverse effects were absent, even though at least one Food and Drug Administration (FDA) safety index was frequently exceeded. Two studies reported microhaemorrhages after long or relatively intense stimulation above safety limits. Another study reported BBB opening and neuronal damage in a control condition, which intentionally and substantially exceeded the safety limits. Conclusion: Most studies point towards a favourable safety profile of TFUS. Further investigations are warranted to establish a solid safety framework for the therapeutic window of TFUS to reliably avoid adverse effects while ensuring neural effectiveness. The comparability across studies should be improved by a more standardized reporting of TFUS parameters.
Introduction
Weak Transcranial Focused Ultrasound Stimulation (TFUS) aims to modulate neural activity by delivering a focused ultrasonic beam to a small target area in the brain. Currently, interest in TFUS is strongly increasing as it holds the promise of a far better spatial resolution than established non-invasive stimulation techniques and of the ability to reach deep brain areas [1] . This might open up intriguing new applications such as epilepsy treatment or presurgical diagnostics prior to electrode implantation for deepbrain stimulation [2, 3] . TFUS is also attractive because it can be readily combined with neuroimaging modalities such as functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) without interfering with the recordings, as it applies acoustic waves rather than electric or magnetic fields.
Firmly establishing its safety profile is a central requirement when aiming to move TFUS from initial pilot studies towards broader testing in humans in-vivo. Reviews on safety and bioeffects of ultrasound (US) in diagnostics [4] and therapy [5] as well as guidelines for the clearance of commercial diagnostic and therapeutic US systems as medical devices [6] are available and constitute a benchmark to avoid harmful effects also for TFUS. Relating the TFUS parameters to these guidelines, as done in many of the published studies, might be considered a conservative choice. However, several aspects put TFUS in a special position. TFUS usually employs lower frequency compared to diagnostic ultrasound (usually upper kHz range vs. MHz) and longer pulse bursts. TFUS has a static focus so that the total energy delivered at the focal point can be higher than the maximal local energy deposit for diagnostic US, as the latter uses scanning approaches. The mechanism-of-action of TFUS is still poorly understood, rendering it more difficult to principally exclude harmful effects. In addition, current findings about the dose-response curve of TFUS [7] suggest that future therapeutic applications might aim to use intensities above the safety limits for diagnostic US in order to increase the robustness of the neural effects. Such a choice requires solid knowledge about the safety margin of TFUS. Along similar lines, accurate dose control for human TFUS is complicated by the presence of the skull, which strongly attenuates the beam. The attenuation depends on the individual skull thickness and composition [8] , which are difficult to account for and lead to conservative intensity choices with an increased risk of underdosing. If the safety margin of TFUS is not well established, the use of more lenient dosing strategies to mitigate this problem is not feasible.
There is a pressing need to establish specific safety guidelines for TFUS. Yet, the current knowledge about the risk-benefit ratio and the therapeutic window of TFUS is still rudimentary because TFUS is at an early stage of development. Indeed, no dedicated phase I safety human study has been performed so far, but the safety profile needs to be systematically investigated and monitored to ensure the patients' safety. However, relevant information is already available today, because some of the published studies on TFUS in animals or humans included safety-relevant tests. Here, we systematically summarize these findings to give an overview of the current state of knowledge about TFUS safety. We start by describing the relevant physical parameters used to characterize the TFUS stimulus. We then shortly describe the known physical mechanisms by which ultrasound can cause tissue damage and we introduce the established safety indices, based on the beam parameters. Finally, we introduce the methods that have so far been applied to test for adverse effects of TFUS, and list the corresponding results. In the discussion, we summarize the implications of the available findings for in-vivo human TFUS applications.
Material and methods

Literature review on the safety of TFUS
For this systematic review, we followed the PRISMA guidelines [9, 10] . Details on the implementation of the PRISMA requirements in our review are stated in the Supplementary material (Table S1 ). Our review was based on searches in PubMed (www.ncbi.nlm.nih. gov/pubmed) and bioRxiv (https://www.biorxiv.org/) for published and pre-published studies, using the keywords 'tFUS', 'LIFUP', 'noninvasive brain stimulation focused ultrasound', 'neuromodulation brain transcranial ultrasound', 'focused ultrasound transcranial brain stimulation' and 'pulsed ultrasound brain stimulation'. The eligibility criteria were low intensity, low frequency TFUS in the brain of animals or humans with safety assessment, without use of microbubbles. Additional sources were reviews of the literature lists of relevant papers, and papers pointed out by the reviewers during the peer-review process. Fig. 1 shows details of the literature search. The last complete search was performed in January 2019 by one of the authors, and the last update was done in June 2019. From each paper, the sonication parameters and the methods used to assess safety and adverse effects were extracted as shown in Table 2 and Table 3 and categorized as described further below. Often, only some of the safety indices were reported. In that case, we give estimated values when possible.
Mechanism of ultrasound neuromodulation
Despite many hypotheses, the exact underlying mechanism of neuromodulation using low-intensity ultrasound is yet to be understood [11] . The initial hypotheses for the ultrasound neuromodulation were thermal effects and acoustic cavitation. While an increase in the tissue temperature could perturb neuronal activity levels, the temperature increase due to low-intensity ultrasound is often less than 0.1 C. Thus, the thermal effects of low-intensity ultrasound are most likely negligible. The second hypothesis is based on acoustic cavitation. This hypothesis postulates that the ultrasound generates nanobubbles in the lipophilic zone of the plasma membrane, which then vibrates according to the pressure variations, alters the local curvature of the bilayer, and changes overall neuronal excitability [12] . However, since nanobubbles are formed at an intensity larger than 100 mW/cm 2 , generation of micro or nanobubbles at the intensity used in standard neuromodulation protocols must be confirmed. The recent hypotheses now focus more on the effects of acoustic radiation forces on the permeability of the ion channels, such as mechanosensitive channels [13] and voltage-gated calcium, sodium, and potassium channels [14] . Another kind of hypotheses includes plasma deformation, which postulates that vibration of surrounding extra-and intracellular environment evokes mechanical changes in either the plasma membrane tension or the lipid bilayer and modulates neuronal activities [14] . Contrary to these works on the mechanisms involved with direct modulation of ion channels and membranes, an indirect in vivo ultrasound neuromodulation through auditory or cochlear pathways has been also recently proposed [15, 16] . These studies demonstrated that ultrasound-induced activities were eliminated or reduced upon transection of the auditory nerves or removal of cochlear fluids. These results raised an important question of whether direct activation of neurons in the intact brain is possible. While more in-depth studies on the experimental protocols such as sharpness of the pulse, pulse repetition frequency, and bone transduction must be performed, these studies underscore the need for a solid understanding of the underlying mechanism of ultrasound neuromodulation [16] .
Physical parameters and safety indices of US waves
A sketch of an experimental setup for TFUS is shown in Fig. 2A , using the stimulation of a rat as example. The main indices used to assess safety are:
I spta (spatial peak temporal average intensity) is the temporal average intensity, calculated at the position of the spatial maximum I sppa (spatial peak pulse average intensity) is the pulse average intensity, calculated at the position of the spatial maximum MI (mechanical index) gives an estimation of the likelihood of inertial cavitation
TI (thermal index) is the steady-state temperature increase in soft tissue during ultrasound sonication TIC (thermal index for cranial bone) is a modification of TI, when the skull is close to the transducer face I spta , TI and TIC are related to the risk of thermal bio-effects, while I sppa and MI are related to the risk of cavitation. The upper limits for these five indices allowed for diagnostic ultrasound are shown in Table 1 . It should be noted that another guideline, IEC standard 60601-2-5 for physiotherapy US equipment, sets an upper limit for the "effective intensity'', defined as the ratio of acoustic output power to effective radiating area, of 3 W/cm 2 . The standard also states that this value should only be reached for short times to prevent substantial heating. The "effective intensity'' of 3 W/cm 2 is usually interpreted as the upper limit for I spta [17e19]. Lee and colleagues [17] compare the intensities used in their study against this limit rather than using the FDA guidelines for diagnostic US.
Complementary to TI, the temperature increase at the target can be calculated as DT max (equation 7 and 8 in Supplementary material) or through the bio-heat equation [20e22] . A more detailed explanation of these indices and formulae can be found in the Supplementary Material.
Mechanisms underlying tissue damage by US
Ultrasound waves may cause harmful effects on tissues via two physical mechanisms, mechanical and thermal. The main mechanical effect is cavitation, in which vapor cavities (or "bubbles") form in the soft tissues during the periods of low pressure (i.e. the minima) of the acoustic wave cycles. Depending on intensity and center frequency, this can result in a stable oscillation (stable or non-inertial cavitation) or can result in violent bubble collapses (inertial cavitation) that create large forces in their neighborhood. The air bubbles can have an endogenous origin (for example in the lungs or intestine), or they can be created by the mechanical wave itself, if the peak rarefaction pressure (i.e. the pressure during the minima) is small enough to allow the liquid to reach vaporization. Alternatively, ultrasound contrast agents (UCA), which contain microbubbles, can be injected for, e.g. clinical purposes [23] or gene and drug delivery [24] .
When a mechanical wave propagates linearly in a medium, its amplitude decreases exponentially starting from the source. The attenuation is caused by both scattering, i.e. the change in the Overview of the parameters used in the reviewed studies. I spta values very often exceeded the limits for diagnostic US. Cases where the I spta values were higher than 3 W/cm 2 , corresponding to the limit for physiotherapeutic US, are highlighted in bold. Also one case in which MI exceeded the limit of 1.9 is marked in bold. If needed, we calculated missing parameters from the available data stated in the paper, which we indicate by "*" in the table. When the peak pressure was reported, MI was calculated using its definition (eq. (2)), and I sppa in water as indicated in Fig. 1 (r ¼ 1000 kg/m 3 , c ¼ 1500 m/s). I spta was finally determined as I sppa x DC. 1) For [27] , only the parameters employed in the safety tests of that study are listed here. 2) For [28] , only the parameters for the main experiment are reported. 3) In Ref. [66] , I spta was determined by using ISI instead of PRP as the total pulse duration; this strongly reduces the value. 4) For [47] , MI, I sppa and I spta are not stated, but authors asserted that they used the same waveform as [62] Response rates of elicited sensations during the FUS procedures were different among subjects (68 ± 28% S1, 59 ± 22% S2, 61 ± 26% S1þS2, average ± sd across subjects). The amplitude of single-pulse TMS MEPs was decreased; the intracortical facilitation was attenuated; no effect on intracortical inhibition. Ultrasound reduces reaction time on a simple stimulus response task (continued on next page) Increasing the I spta increase the motor movement robustness, assessed by visual assessment with unfocused US and mFUS, and the normalized success rate in mFUS. optical fiber based thermal sensor [36] ), maximum temperature increase, (equation (7) to estimate DTmax), magnetic resonance thermometry (MR th.) and the bioheat equation for the temperature increase; motor task (m.t.) or other for behavioral assessments. 1) safety assessed in rats that did not undergo pentylenetetrazol (PTZ) injection to induce epileptic activity [2] or photothrombosis procedure to induce ischemic stroke [19] . direction of wave propagation due to the presence of microscopic obstacles along the beam, and absorption. Absorption is the process by which the wave energy is converted into heat, and therefore the medium is heated. Several ways to model or monitor the resulting temperature increase in the medium exist, and they will be further discussed below.
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Types of adverse and side effects caused by TFUS
In this section, we summarize the potential adverse and side effects, which have so far been tested in TFUS studies, and briefly outline the employed techniques to assess the occurrence of these effects. The majority of results were obtained in animal studies, which tested for the following effects:
Blood-brain barrier (BBB) opening: The BBB is a semi-permeable membrane formed by endothelial cells which separates the vessels and the central nervous system (CNS) [25] . Air bubbles subjected to cavitation can break the BBB. Exploiting this effect, TFUS combined with US contrast agents is tested as a method for targeted drug delivery [26] . However, BBB opening is undesired for normal TFUS. Assessing BBB integrity is usually based on the intravenous injection of a substance, which cannot cross the barrier under normal conditions, prior to sonication. It is then tested whether TFUS causes the substance to diffuse into brain tissue. The dyes fluorescein isothiocyanate-dextran (FITCdextran) [27] , trypan blue [28e30] or Evans blue [31] have been used for this purpose, and their presence inside the brain was investigated in post-mortem microscopy analyses of brain slices. Alternatively, an MRI contrast agent (a gadolinium chelate) was injected before the stimulation and its penetration into brain tissue was tested by assessing the MRI signal change due to the contrast agent [29] . Bleeding: The occurrence of bleeding has been investigated using tissue staining, in particular hematoxylin and eosin (H&E) staining [2,19,22,28,32e38] , which reliably stain blood cells. Yet, H&E staining is not specific to blood cells and thus requires experience to correctly interpret the results.
Cell death and damage:
A general approach to qualitatively analyze the presence of cell death and damage is through H&E staining [2,19,21,22,28e30 ,32e40], as described above, cresyl violet Nissl staining [22] , or luxol fast blue dye (LFB) [21] , used to identify myelin in nervous tissue. Cell death can be of two types, apoptosis and necrosis. While apoptosis is part of the normal life cycle of the cells, necrosis is harmful and triggered by external factors or disease. It is possible to differentiate between both types of cell death based on morphological criteria, but this requires experience [41] . Additional techniques specifically label apoptotic cells and have therefore been used to distinguish between apoptosis and necrosis. For example, the presence of fragmented DNA is a sign of apoptosis, and not necrosis, and it can be labeled by terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling (TUNEL) assay [2, 29] . Alternatively, since apoptosis is mediated by caspase [42] , standard immunocytochemistry techniques with antibodies against cleaved caspase-3 can be used [27, 30] . An alternative approach to detect cell damage is staining for acidophilic cells, for example with VAF (vanadium acid fuchsin) [30, 43] . Acidophilia refers to the property of cells of staining readily with an acid dye and occurs after acute neuronal damage and death in brain ischemia.
Finally, also transmission electron microscopy has been used to quantitatively observe the effect of ultrasound on brain ultrastructure (postsynaptic density, docked vesicles, etc.) [27] . It has been shown that neural trauma causes an abnormal increase in the number of astrocytes [44] that can be detected by the expression of GFAP (glial fibrillary acidic protein) [30, 31, 39] . One study assessed possible permanent tissue damage after sonication in rats using MRI [39] . Irreversible changes of neural activity: Recordings after the sonication can determine whether changes in neural activity are reversible and characterize the duration of recovery. The effects on local neural activity in the TFUS target region can be detected directly via invasive recordings or voltage sensitive dyes [31] or Ca 2þ imaging in transgenic mice that express the green fluorescent calcium indicator [31] . TFUS-related changes in extracellular concentrations of excitatory and inhibitory neurotransmitters such as glutamate and l-aminobutyric acid (GABA) can be measured via microdialysis techniques [37] . TFUS has also been combined with measurements of the forelimb and hindlimb responses to epidural cortical stimulation (ECS) to assess the cortical excitability changes after sonication [45] . Alternatively, electroencephalography (EEG) [29] , functional MRI [22, 46] , PET [32] , measurements of peripheral muscle evoked potentials (MEP) [47] , sensory evoked potentials (SEP) [48] , somatosensory evoked potentials (SSEP) [21] , visual evoked potentials (VEP) [49] or auditory evoked potentials (AEP) [39] give non-invasive but less specific measurements of neural activity changes. Undesired changes in animal behavior: TFUS may affect normal behavior in unintended ways. In animals, this is controlled by monitoring of every day behavior, like food uptake, defecation and movement behavior and checking for signals of pain and distress or change in weight [28e30,32e34, 45, 50] . In addition, tasks such as the rotorod task and wire-hanging task allow for quantitatively assessing the impact of TFUS on specific aspects of behavior [27] . One study induced ischemic stroke in mice and compared the behavioral changes of the mice which were treated with TFUS via a balance test and an adhesive removal test [19] .
Adverse effects can be caused by cavitation or tissue heating. As outlined above, cavitation is prevented by controlling the pressure levels. While the temperature increase in the brain can be roughly estimated using Equations (7) and (8) in the Supplemetary Material [17, 19, 27, 30, 34, 35, 48, 51] , some studies inserted a thermocouple [27, 28, 33, 45, 48] or an optical fiber based thermal sensor [36] in the brain of the animal after craniotomy to track the temperature change in real time during sonication. A non-invasive alternative to this approach is measuring the temperature increase with thermocouples in a phantom [33] , or MR thermometry [21, 29, 39, 52] , which exploits temperature sensitive MR parameters such as the water proton resonance frequency, or T1 and T2 relaxation times [53] .
So far, most TFUS studies used animal models. Tests for adverse effects in the few human studies were based on neurological examinations and/or structural MR imaging before and at one or several time points after the experiment [17, 51, 54] . In some of the studies, the participants were additionally contacted by telephone 2 months after the experiment and interviewed about any changes in their mental and physical health status, including experiences of any discomfort [17, 51] . A pre-print manuscript [55] presents results of phone interviews based on a 'Participant report of symptoms questionnaire' of 64 participants who had participated in one or more of seven human TFUS experiments before.
Results
Studies screened in this review
This systematic review follows PRISMA guidelines [9, 10] , and the PRISMA checklist can be found in the Supplementary Methods (Table S1 ). The reviewing process shown in the PRISMA diagram Flow (Fig. 1 ) resulted in the selection of 31 peer-reviewed and 2 pre-published studies included in this review. From each of those papers (a complete list with citations is shown in Table 2 ), the sonication parameters (Table 2 ) and the methods used to assess safety and adverse effects (Table 3) were extracted and categorized as described further below. Often, only some of the safety indices were reported. In that case, we give estimated values when possible. The risk of bias was assessed and is reported in a separate section in the Supplementary Material.
BBB opening
BBB opening did not occur in any of the included studies [28e30], except for two cases where it was intentionally provoked in control conditions [27, 31] , using a high I sppa of 280 W/cm 2 [31] or an ultrasound contrast agent [27] .
Bleeding
Several studies [2,19,22,28,32,33,36e38 ] tested for bleeding, without finding evidence for it. A further study [34] tested different sonication parameters on eight sheep in total, and reported four animals with micro-hemorrhages in the primary visual cortex after undergoing 600 sonications at 6.6 W/cm 2 I sppa (6 repetitions of 100 sonications, with 30 s gaps). While the reported value for I sppa is within FDA limits, our calculated value for I spta of 3.3 W/cm 2 is exceeding the diagnostic limit, and is also slightly higher than the limit for physiotherapeutic US of 3 W/cm 2 . Interestingly, a sheep undergoing a single sonication at an I sppa of 13.4 W/cm 2 did not present micro-hemorrhages. In another study [35] , 1 of 37 rats was
exposed to a high intensity (11.2 W/cm 2 I spta ) for a short period of time (<9 s using 1 ms TBD, 50% duty cycle and 300 ms SD). It exhibited several areas containing hemosiderin, which indicate the potential of local bleeding, while none of the other animals showed any sign of bleeding.
Cell damage or death
Most of the studies testing for cell damage or death [2,19,21,22,27e30 ,32e40] did not observe harmful effects of TFUS. One recent study [31] observed no differential GFAP expression between the control and sonicated hemisphere for I sppa ¼ 0.69 W/ cm 2 , suggesting the absence of neural trauma. However, an increased number of astrocytes was observed for a control condition with I sppa ¼ 280 W/cm 2 (~1.5 times above the FDA limit).
Interestingly, no damage was observed even when AEP was not fully recovered after one month [39] in rats.
Long-term change of neural activity
Yoo et al. [29] tested parameter ranges for excitatory and inhibitory TFUS effects in craniotomized rats. While excitatory effects were very short-termed, suppression effects lasted several minutes. A reduction in the EEG response of up to 80% and a corresponding reduction of the BOLD signal that both lasted up to 10 min were reported for a long sonication duration of 9 s. Dallapiazza et al. [21] observed peak electrophysiological suppression in SSEP 5 min post-treatment, and the values returned to near baseline within 20 min. A further study [31] tested the facilitatory effects of ultrasound on somatosensory evoked potentials by measuring the changes in fractional fluorescence in the brains of mice dyed with voltage sensitive dyes. The TFUS-related changes disappeared within 20 min after ultrasound stimulation. Yang et al.
[37] observed a decreased extracellular GABA level (approximately 20% below baseline) compared to a control group that lasted up to 100 min after the sonication ended. The same effect was not observed for glutamate. Gulick et al. [45] showed that TFUS significantly suppressed forelimb and hindlimb responses to ECS for several minutes after the stimulation blocks, even though effects immediately after single, short TFUS trials were absent. Kim et al. [32] observed a local increase in glucose metabolism induced by FUS to rat brain. This effect was demonstrated via PET imaging, which was started 20 min after the sonication and performed for 1 h. After that time, the metabolism had still not returned to baseline. In a work [22] on primates, the authors observed change in functional connectivity after a long sonication of 40 s at I spta ¼ 7 W/cm 2 . The change lasted for more than 1 h after sonication. A similar effect was observed in a related work [46] , where they used a sonication of 40 s at a maximum I spta of 15.3 W/cm 2 . Yoo et al. [48] observed that the SEP signals after 10 min sonication were distinctively different compared to the control condition, even 35 min after the sonication. Daniels et al. [39] observed a full recovery of AEP amplitudes in rats within maximum 1 week posttreatment with I sppa ¼ 2. One study [19] induced ischemic stroke in mice and found a better sensorimotor performance in mice that underwent 20 min TFUS session via a balance test and an adhesive removal test. These improvements lasted for 4 weeks after treatment, suggesting an enhancement in brain plasticity. In the same study, the TFUS treatment in cerebellar LCN significantly lowered the percentage change in increased water content and tissue swelling in the ipsilateral hemisphere to the stroke.
Animal behavior
Several studies tested for changes from normal daily behavior after the sonication studies [28e30,32e34,45,50], but did not find any abnormalities. A single study also employed behavioral tasks [29] (rotorod running task and wire-hanging task), without revealing differences in motor performance.
Temperature
Theoretical calculations based on Equations (7) and (8) in the Supplementary Methods suggest that "typical" TFUS parameters used so far in most studies cause negligible temperature increases in brain tissue [17, 19, 27, 30, 34, 35, 48, 51] . In a recent study [22] , this was partly confirmed using the more realistic bio-heat equation to estimate the temperature increase after 40 s of TFUS through a 3 mm thick skull, with an I spta ¼ 7 W/cm 2 in the brain. The maximal increase in the brain was less than 0.2 C. Interestingly, however, they found rather strong increases in the skull (2.8 C). Also experimental results show mostly only small temperature increases due to sonication [27, 28, 33, 36, 48] . However, it is important to note that the overall temperature increase depends on the combination of several TFUS parameters. For example, one study [36] reported a measured peak temperature increase of 0.2 C for an extended stimulation (~30 min) at a low I spta 230 mW/cm 2 at 1 MHz (1.6 C at 5 MHz for otherwise same parameters). In contrast, another study [45] reported a temperature increase up to 3 C after two blocks of 5 min stimulation at 200 kHz, separated by a 2 min break, at I spta ¼ 4.5 W/cm 2 and a MI ¼ 3.1 (higher than the allowed limit). Both studies applied longer durations than used in most other TFUS studies so far, but the combination with the higher I spta caused noticeable temperature rises in the second study. A temperature increase of 0.5 C was reported through MR thermometry after 30 s sonication at I sppa ¼ 9.9 W/cm 2 [52] .
Another study [39] reported temperature variation within the measurement noise level of the baseline temperatures (±2 C) with MR thermography. The strongest effect was reported by a study using MR thermometry (sensitivity 0.3 ± 0.06 C [29] ), demonstrating an increase of~0.7 C in the sonicated area [29] , using an I sppa ¼ 23 W/cm 2 for 27 s. Dallapiazza et al. [21] showed a negligible temperature increase during treatment using both MR thermometry and estimations based on the bio-heat equation.
Findings from human studies
In a recent preprint work [47] , the authors tested the effects of ultrasound stimulation on motor cortex excitability measured by single-pulse transcranial magnetic stimulation (TMS). They report significant changes in the recorded muscle responses to TMS only when it was applied during, but not after, sonication. Follow-up neurological exams and anatomical MRIs after the TFUS experiment did not reveal any abnormalities or changes in the mental or physical status, nor any discomfort associated with the procedure [17, 51, 54] . Follow-up interviews at later time points confirmed those observations. A recent study published as preprint [55] presents results from a follow-up questionnaire after TFUS that could be obtained from 64 out of in total 120 participants. Seven subjects reported mild or moderate symptoms (mild neck pain, scalp tingling, headache, difficulty paying attention, muscle twitches and anxiety) that they felt were possibly or probably related to the experiment. These initial symptoms disappeared upon follow-up. The authors found a linear correlation (r ¼ 0.797, p ¼ 0.0319) between I sppa and the occurrence of observed symptoms among the 7 subjects who reported mild to moderate symptoms that were perceived as 'possibly' or 'probably' related to participation in TFUS experiments.
Discussion and conclusions
Harmful effects of TFUS were absent in the majority of the 33 studies reviewed here. In two cases, microhemorrhages occurred in a subset of the tested animals when using a high I spta of 11.2 W/cm 2 for a short duration [35] or an I spta of 3.3 W/cm 2 for a high number of sonications (500) given at a relatively short ISI of 1s [34] . Both doses are clearly above the safety limits of the FDA guidelines for diagnostic US and above the IEC standard 60601-2-5 for physiotherapy US equipment. However, this also holds for several other included studies, where no adverse effects were reported. While the parameters chosen in one of the studies [35] did not result in substantial heating, as also pointed out by the authors, the high I spta of 11.2 W/cm 2 differentiates it from many other TFUS studies. That might indicate that mechanical effects caused the microhemorrhages, even though the limits for MI and I sppa were not exceeded. However, as this was observed in only one of the tested animals, this conclusion remains very speculative and a replication including sham controls would be favorable to ensure that the microhemorrhages were indeed related to TFUS. In the second study [34] , the chosen parameter combination might have led to a high total energy deposit, opening the possibility that a thermal mechanism underlay the adverse effects that occurred in four animals. For example, Gulick et al. [45] observed a temperature increase of 3 C for a less intense protocol using an I spta ¼ 4.5 W/cm 2 and in total 180 sonications in a time period of 13 min. It seems reasonable to assume that heating might have been even higher in the four animals that showed microhemorrhages in Ref. [34] and indicates that calculating the temperature increase for a single sonication, as done in Ref. [34] , can strongly underestimate the real increase. While I sppa stayed below the safety limit in all studies, MI exceeded the limit in two studies [45, 46] and I spta exceeded the FDA limits for diagnostic US in soft tissue in 14 out of the 20 studies in which I spta was reported or could be calculated post hoc (values after cranial transmission or for craniotomized animals). I spta was also above the physiotherapeutic limit in 11 of the 20 studies. This suggests that I spta is the most sensitive safety index in case of TFUS and, unlike current practice, should be reported so that it can be followed up by a more detailed estimation of the thermal effects when its limits are exceeded. We consider this relevant as the current studies indicate that TFUS parameters within the FDA limits for diagnostic US might often lack neural stimulation effectiveness. For example, an I spta of around 2 W/cm 2 for pulsed waves and 4 W/ cm 2 for continuous waves was necessary to reach a 50% success rate for stimulation at 500 kHz [7] . Similarly, while many studies included in this review reported neural effects for parameters within the safety limits [2, 19, 27, 31, 33, 48, 49, 52, 56] , several studies found stable effects only when exceeding at least one of the safety indices ([28e30, 34, 35] and Table 2 ). In addition, recent studies show that heating of the skull (potentially causing indirect heating of soft tissue) and/or brain tissue can reach several degrees for more intense and long protocols [22, 45] . The systematic assessment of heating will thus be relevant in future studies that might aim at extending the parameter envelope of TFUS and should be part of any safety test of new sonication regimes in particular for human TFUS.
It is worth noting that the safety limit of 720 mW/cm 2 for I spta , which was generally used in TFUS studies so far and which we also applied here, was introduced to limit the heating in soft tissue. In case of transcranial US, the FDA limits for diagnostic US actually apply an even stricter limit of 94 mW/cm 2 for I spta to prevent excessive heating of the skull, which absorbs most of the beam energy. It seems that almost none of the studies published so far reported neural effects for intensities below this threshold. However, it is important to stress that both limits are based on worstcase scenarios and exceeding them does not necessarily mean that strong heating occurs. Rather, the FDA standard for diagnostic US requires a case-by-case estimation of the maximum temperature rise in soft tissue and skull once they are exceeded, specific for the used ultrasound parameters and setup. Simulations of the propagations of the TFUS beam through the skull, combined with evaluations of the bio-heat equation for TFUS [22] , might be valuable tools that allow realistic estimates of the amount of heating for new sonication regimes on a more standard basis. The neural aftereffects can exceed 1 h [22, 32, 46] , making TFUS a potent neuromodulation modality. This is encouraging for therapeutic applications. In contrast to diagnostic US, future TFUS applications might resort to repeated sessions over extended time periods to achieve and maintain therapeutic efficacy. As such, a safety framework will also need to cover these more intense settings (see, e.g. Refs. [57, 58] for a related example of adverse effects that only occurred after repeated applications in case of transcranial direct current stimulation) or combinations of TFUS with other brain stimulation techniques. This will require safety studies that specifically test this parameter space in order to inform an international consensus on accepted settings and procedures, similar to established non-invasive brain stimulation methods [59] . Along similar lines, in the few TFUS studies performed in humans so far, the type and extent of follow up exams differed strongly [17, 51, 54, 55] . This suggests a need for guidelines that provide a secure framework for experimental settings and practical procedures, including mandatory safety screening and appropriate followup procedures. For example, the importance of establishing best practices also for apparently simple procedures was highlighted in a recent review [60] of low-intensity low-frequency US (20e100 kHz), showing that US can cause skin damage due to inertial effect cavitation in the coupling gel if non-degassed gel is employed.
Along similar lines, guidelines are important to prevent intensity hotspots that can occur due to unintended standing waves and focusing effects of the skull. While these effects more likely emerge in small animals [50] , they have been shown to be also relevant in non-human primates for targets close to the skull base such as the amygdala [46] . Moreover, a retrospective modeling study [61] suggests that unwanted secondary hotspots might have been the cause of intracerebral hemorrhages that occurred in a clinical trial on transcranial low frequency ultrasound for sonothrombolysis [68] and that resulted in the early termination of the trial. Finally, the reviewed studies differed in regards to the choice of the stated safety-relevant parameters and the way those were assessed. A more standardized reporting of the relevant pulse parameters and of all safety indices of the FDA guidelines is a prerequisite for the development of future TFUS guidelines for human applications. Accurate estimation of the TFUS intensity after cranial transmission is particularly challenging in humans, as it has to rely on hydrophone measurements based on "representative" skull samples or computer simulations [17, 51, 62] . The uncertainty range of the intensity estimates obtained by these procedures seems still unclear [63, 64] , and contributes to variations in the values reported across studies. As such, it seems useful that future studies additionally state intensity values for a pure water background to ensure good comparability of the baseline TFUS parameters.
Conflicts of interest
None declared.
